Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Morice

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Gynecologic Oncology|June 2, 2016
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancerS Gouy, G Ferron, O Glehen, et al.
Gynecologie, Obstetrique & Fertilite|April 30, 2003
[Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure]P Morice, A Rodrigues, P Pautier, et al.
European Journal of Gynaecological Oncology|June 17, 2003
Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patientsP Morice, A Rodriguez, A Rey, et al.
Brachytherapy|March 7, 2017
Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinomaP Castelnau-Marchand, A Escande, R Mazeron, et al.
Gynecologie, Obstetrique & Fertilite|May 5, 2004
[Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?]A Recoules-Arche, R Rouzier, A Rey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2008
Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumorT de La Motte Rouge, P Pautier, P Duvillard, et al.
Bulletin Du Cancer|December 17, 2009
[Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France]I Ray-Coquard, P Pautier, E Pujade-Lauraine, et al.
Bulletin Du Cancer|November 19, 2009
[New drugs and targeted therapeutic agents in ovarian cancer]T de La Motte Rouge, M-C Petrella, J Michels, et al.
Cancer|December 18, 2001
Results of conservative treatment in epithelial ovarian carcinomaP Morice, F Wicart-Poque, A Rey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Prognostic factors for patients with advanced stage serous borderline tumours of the ovaryP Morice, S Camatte, A Rey, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Gynecologic Oncology|June 2, 2016
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancerS Gouy, G Ferron, O Glehen, et al.
Gynecologie, Obstetrique & Fertilite|April 30, 2003
[Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure]P Morice, A Rodrigues, P Pautier, et al.
European Journal of Gynaecological Oncology|June 17, 2003
Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patientsP Morice, A Rodriguez, A Rey, et al.
Brachytherapy|March 7, 2017
Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinomaP Castelnau-Marchand, A Escande, R Mazeron, et al.
Gynecologie, Obstetrique & Fertilite|May 5, 2004
[Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?]A Recoules-Arche, R Rouzier, A Rey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2008
Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumorT de La Motte Rouge, P Pautier, P Duvillard, et al.
Bulletin Du Cancer|December 17, 2009
[Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France]I Ray-Coquard, P Pautier, E Pujade-Lauraine, et al.
Bulletin Du Cancer|November 19, 2009
[New drugs and targeted therapeutic agents in ovarian cancer]T de La Motte Rouge, M-C Petrella, J Michels, et al.
Cancer|December 18, 2001
Results of conservative treatment in epithelial ovarian carcinomaP Morice, F Wicart-Poque, A Rey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Prognostic factors for patients with advanced stage serous borderline tumours of the ovaryP Morice, S Camatte, A Rey, et al.
Pageof 24